» Articles » PMID: 26733989

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Jan 7
PMID 26733989
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A key factor in the effectiveness of the seasonal influenza vaccine is its immunological compatibility with the circulating viruses during the season. Here we propose a new bioinformatics approach for analysis of influenza viruses which could be used as an efficient tool for selection of vaccine viruses, assessment of the effectiveness of seasonal influenza vaccines, and prediction of the epidemic/pandemic potential of novel influenza viruses.

Citing Articles

Prediction of Antigenic Distance in Influenza A Using Attribute Network Embedding.

Peng F, Xia Y, Li W Viruses. 2023; 15(7).

PMID: 37515165 PMC: 10385503. DOI: 10.3390/v15071478.


Predicting Antigenic Distance from Genetic Data for PRRSV-Type 1: Applications of Machine Learning.

Makau D, Prieto C, Martinez-Lobo F, Paploski I, VanderWaal K Microbiol Spectr. 2022; 11(1):e0408522.

PMID: 36511691 PMC: 9927307. DOI: 10.1128/spectrum.04085-22.


Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks.

Lee E, Tian H, Nakaya H Hum Vaccin Immunother. 2020; 16(11):2690-2708.

PMID: 32750260 PMC: 7734114. DOI: 10.1080/21645515.2020.1734397.


Evolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015.

Mahmoud S, Mostafa A, El-Shesheny R, Seddik M, Khalafalla G, Shehata M Pathogens. 2019; 8(4).

PMID: 31703251 PMC: 6963730. DOI: 10.3390/pathogens8040224.


Optimizing the impact of low-efficacy influenza vaccines.

Sah P, Medlock J, Fitzpatrick M, Singer B, Galvani A Proc Natl Acad Sci U S A. 2018; 115(20):5151-5156.

PMID: 29712866 PMC: 5960327. DOI: 10.1073/pnas.1802479115.


References
1.
Pebody R, Warburton F, Ellis J, Andrews N, Thompson C, von Wissmann B . Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015; 20(5):21025. View

2.
Rajao D, Gauger P, Anderson T, Lewis N, Abente E, Killian M . Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States. J Virol. 2015; 89(22):11213-22. PMC: 4645639. DOI: 10.1128/JVI.01675-15. View

3.
Schmier S, Mostafa A, Haarmann T, Bannert N, Ziebuhr J, Veljkovic V . In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses. Sci Rep. 2015; 5:11434. PMC: 4473683. DOI: 10.1038/srep11434. View

4.
Nobusawa E, Sato K . Comparison of the mutation rates of human influenza A and B viruses. J Virol. 2006; 80(7):3675-8. PMC: 1440390. DOI: 10.1128/JVI.80.7.3675-3678.2006. View

5.
Veljkovic V, Niman H, Glisic S, Veljkovic N, Perovic V, Muller C . Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Struct Biol. 2009; 9:62. PMC: 2760557. DOI: 10.1186/1472-6807-9-62. View